Skip to content

13F-HR filed by Carlyle Group Inc.

Carlyle Group Inc. filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-03, with 32 holding rows worth $1,586,342,838.

Accession
0000898432-24-000359
Filed
2024-05-03
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A combination report, 32 entries on the cover page, a total value of $1,586,342,838 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,586,342,838 with VALUE read as dollars as filed, 13F file number 028-15025. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUIDELORTHO CORP COM219798105Stock12,460,183$597,341,173dollars as filed
ZOOMINFO TECHNOLOGIES INC COMMON STOCK98980F104Stock26,244,474$420,698,919dollars as filed
SOLENO THERAPEUTICS INC834203309COM4,071,562$173,122,816dollars as filed
VITRU LTDG9440D103COM6,246,471$94,009,389dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS2,457,500$39,442,875dollars as filed
GETTY IMAGES HOLDINGS INC374275105CL A COM9,212,799$38,233,118dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK3,496,808$37,101,133dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW1,066,189$31,303,309dollars as filed
HILLEVAX INC43157M102COM1,838,486$30,500,483dollars as filed
GDS HLDGS LTD SPONSORED ADS36165L108ADR4,072,624$27,082,952dollars as filed
SEACOR MARINE HLDGS INC COM78413P101Stock1,314,164$18,319,446dollars as filed
Q32 BIO INC746964105Common Stock1,102,741$18,073,925dollars as filed
INVITATION HOMES INC COM46187W107REIT477,500$17,003,775dollars as filed
CUBESMART COM229663109REIT220,500$9,971,010dollars as filed
ADICET BIO INC007002108COM2,948,718$6,900,000dollars as filed
KRISPY KREME INC50101L106COMMON STOCK340,748$5,191,295dollars as filed
RENEO PHARMACEUTICALS INC75974E103COM2,698,957$4,453,279dollars as filed
SMART SH GLOBAL LTD83193E102ADS4,810,209$3,162,231dollars as filed
EFFECTOR THERAPEUTIC EQUCLASS EQUITY28202V207COMMON STOCK192,884$2,721,593dollars as filed
SUNPOWER INC20460L104COM4,936,483$2,715,066dollars as filed
SPRUCE BIOSCIENCES INC85209E109COM2,896,518$2,276,663dollars as filed
N-ABLE INC COMMON STOCK62878D100Stock93,732$1,225,077dollars as filed
SOLARWINDS CORP83417Q204COM NEW93,735$1,182,936dollars as filed
Broadcom Inc.11135F101COM755$1,000,566dollars as filed
NU HLDGS LTDG6683N103ORD SHS CL A72,341$863,028dollars as filed
NUCANA PLC67022C106ADR3,333,333$845,333dollars as filed
DOORDASH INC CL A25809K105Stock4,156$572,364dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW9,620$364,790dollars as filed
META DATA LIMITED68276W400SPONSORED ADS314,400$240,610dollars as filed
CONFLUENT INC20717M103CLASS A COM7,683$234,485dollars as filed
EXICURE INC30205M200COM NEW281,636$160,533dollars as filed
MOLECULAR TEMPLATES INC608550208COM13,333$28,666dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000898432-24-000359this filing2024-05-03acceptance time not in the bulk data set